• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Mankind Pharma targets Rs 1,000-cr turnover

      Posted AtSify.com

      Mankind Pharma has set itself an ambitious target of achieving a turnover of Rs 1,000 crore in the next five years.To achieve this, the company plans to invest Rs 70 crore in the next two years in scaling up its manufacturing capability and investing in research and development (R&D).

      According to R.C. Juneja, Managing Director, Mankind Pharma, a new manufacturing plant complying with the US Food and Drug Administration standards is being set up in Poanta Sahib, Himachal Pradesh."Mankind will set up a latest R&D facility in the national capital region (NCR). This facility will have capabilities in the areas of formulations development, new drug delivery systems, bio-equivalence studies, contract research and new drug discovery," he said.

      Mankind Pharma is also planning to export its products to other semi-regulated markets of South East Asia, South African and some CIS countries. "We hope that exports will contribute 10 per cent to the annual turnover," said Rajiv Juneja, Director, Marketing. In India too, it will add a new division to its existing ones by the end of 2007 which will comprise oncology and other critical care segment drugs.

      The domestic formulations business is expected to grow at 40 per cent. Domestic sales will continue to be the cornerstone of the growth strategy. "Currently, we have a 1900 strong field force. Over the next two years, this number is likely to grow to 3,000 people," he added.

      December 16, 2005


      Share this Article!

    Back to top^